Skip to main content

Military Health System

Army CID forensics team on the frontline of the COVID-19 pandemic

Image of Three lab technicians in full PPE looking at computer screen. Dr. Roman Aranda, Supervisory Chemist, and Dr. Bo Liu, Chemist, process samples on the Panther Fusion at the Dwight D. Eisenhower Army Medical Center at Fort Gordon, Georgia. (Photo by: Jeffrey Castro.)

Recommended Content:

Coronavirus & the MHS Response | Coronavirus & the MHS Response

In the middle of March as the COVID-19 pandemic spread across the United States, the Army made mission adjustments to focus on protecting the force, posturing for global operational readiness, and supporting the national effort to fight the new novel coronavirus.

"U.S. Army researchers were critical during the SARS epidemic, the Zika virus and the Ebola outbreak as they helped develop antivirals and vaccines," said Ryan McCarthy, Secretary of the Army, in an April 1, U.S. Army press release. "They've done it before and they will do it again."

During this timeframe, a team from the U.S. Army Criminal Investigation Command’s Defense Forensic Science Center’s (DFSC) Forensic Exploitation Directorate (FXD) collectively identified the required skills, training and equipment needed to conduct COVID-19 testing.

“At the early onset of the COVID-19 pandemic, we (DFSC FXD) understood the severity and global impact the virus would have,” said Crystal Allen, chief, Forensic Exploitation Branch 2 within the FXD. “We knew very quickly that given the organic skillset of the FXD examiners that we could assist the medical community with testing. Our support ultimately provided the Department of Defense with additional resources across the globe to support the ever-increasing demand for COVID-19 testing.”

Located on the Gillem Enclave in Forest Park, Georgia, the DFSC's mission is to provide full-service forensic and biometric support to Army and Department of Defense (DOD) entities worldwide. This includes the subordinate units of U.S. Army Criminal Investigation Laboratory, FXD, Biometrics Operations Directorate, and the Office of Quality Initiatives and Training. The FXD houses the capability to deploy a scalable and modular forensic exploitation team to provide the joint force commander or combatant command with a deployable forensic capability.

Five months later, a team from FXD continues to support COVID-19 testing in support of military forces.

According to Allen, the initial planning team of seven individuals formed in mid-March and was tasked early on with concept development.

The team used their vast scientific and operational expertise to learn proper medical testing procedures and requirements in order to establish a way ahead to support the DOD.

Despite not having used the Panther Fusion, BioFire, or Gene Expert platforms before, the FXD examiners used their knowledge and skillsets in complex scientific instrumentation and sample handling to adapt, said Allen. These platforms utilize polymerase chain reaction (PCR) technology, much like the FXD examiners utilize to conduct forensic DNA testing.

“FXD's support to COVID processing improved the U.S. military's readiness and provided enhanced value to the U.S. government,” said Allen. “The FXD's support helped to identify service members testing positive within basic training formations, deploying units, mobilized National Guard units, Navy ships, and Marine Expeditionary Forces so commanders could isolate those infected personnel in order to preserve the readiness of the remainder of the Joint Forces.”

Since March, dozens of FXD Forensic DNA examiners, latent print examiners, and explosive/drug chemists have deployed to work in military medical treatment facilities at Fort Gordon, Georgia; and Camp Humphreys, Korea in support of U.S. Army Medical Command (USAMEDCOM). They have also deployed to Camp Ripley, Minnesota, in support of a mobile medical lab set up to handle COVID-19 specimen testing in remote locations.

Allen said, CID’s FXD team transformed their current forensic instrumentation and software into a viral testing capability and also modified five mobile forensic laboratories to meet the needs of medical testing facilities for rapid deployment into austere locations.

The mobile forensic labs have aided in expedited testing and allowed military personnel to be tested without having to mail tests to another medical location.

The transformation from a forensic science capability into a medical testing capability required exhaustive research, planning, contract modifications and countless hours of coordination with the DFSC staff, CID staff, USAMEDCOM, numerous scientific vendors, the Center for Disease Control and the U.S. Food and Drug Administration, Allen stated.

The FXD has significantly impacted the fight during the COVID-19 pandemic with noticeable results by providing more than 8,100 hours of support and processed more than 47,530 DoD COVID-19 samples as of Aug. 11. In addition to the significant number of samples the FXD team was able to process, they were also able to provide their USAMEDCOM partners with novel testing concepts and efficient processing mechanisms based on their experience working in high OPTEMPO forensic laboratories.

The team has processed samples submitted from Basic Training formations at Fort Benning, Georgia; deploying units from Fort Campbell, Kentucky; mobilized National Guard units preparing for rotations at the Combat Training Centers; forward deployed military units along the Demilitarized Zone (DMZ) in South Korea; and Marine Expeditionary Forces in Okinawa, Japan, to name a few.

“Our FXD Teams continue a high level of support to USAMEDCOM with COVID-19 Testing,” said COL Jeremy Willingham, executive director, DFSC, after processing 8,000 swabs in one week alone. “In one single day the FXD team accessioned, packaged, and shipped 2,820 specimens from the USS America, USS Ronald Reagan, USS New Orleans, U.S. Naval Hospital in Okinawa, and Camp Humphreys.”

The primary mission for FXD is global forensic exploitation support. However, the forward leaning innovative thinking led to FXD truly supporting a full range of military operations, to include the global fight against this novel threat, said Allen.

You also may be interested in...

Guam Plasma Collection

Photo
7/2/2020
Guam Plasma Collection

U.S. Naval Hospital Guam Hospitalman Apprentice Rebekah Morrison records the weight of convalescent plasma units collected from Sailors who recovered from COVID-19. (U.S. Navy Photo by Jaciyn Matanane/Released)

Recommended Content:

Coronavirus & the MHS Response

Supplemental Guidance 10 for Military Medical Treatment Facilities and Military Dental Treatment Facilities Directors in regards to Coronavirus Disease 2019

Publication
7/1/2020

Recommended Content:

Coronavirus & the MHS Response

How the military stays ready during disease outbreaks

Article
6/29/2020
Headshot of Dr. Sanchez

A Q&A with a health surveillance professional at Armed Forces Health Surveillance Branch

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus & the MHS Response

MHS Minute: DoD Focused on COVID-19 Testing and Treatment

Video
6/25/2020
MHS Minute: DoD Focused on COVID-19 Testing and Treatment

Have you recovered from COVID-19, or tested positive for antibodies? Consider donating convalescent plasma. To learn how, go to https://www.militaryblood.dod.mil/

Recommended Content:

Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

Defending the Homeland: A Determined Descendant and a Navy Hospital's Response to COVID-19

Article
6/9/2020
Image of Navy captain, wearing a mask, standing next to a piece of paper on the wall

Althoff and her team at the Quality Management directorate serve as a locus of coordination for clinical support operations.

Recommended Content:

Public Health | Coronavirus & the MHS Response | Coronavirus & the MHS Response

DOD Establishes Collaborative Virus Genetic Sequencing Capability for COVID-19

Article
6/5/2020
Image of two scientists in masks looking at a computer monitor

COVID-19 sequencing process will provide military commanders and other DOD leadership with critical information to guide force health protection decision-making.

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus & the MHS Response | Global Emerging Infections Surveillance

Defending the Homeland: Putting talent to work

Article
6/5/2020
Three military personnel wearing masks

One seamstress took it upon herself to create face coverings for her colleagues.

Recommended Content:

Coronavirus & the MHS Response

Communication to ABA Providers Regarding Continued Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Publication
6/3/2020

TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.

Recommended Content:

Coronavirus & the MHS Response | Information for Patients: About TRICARE

TRICARE Reserve Select (TRS) Health Plan Reinstatement During COVID-19 National Emergency

Fact Sheet
6/2/2020

Fact sheet explaining that explaining that TRICARE Reserve Select beneficiaries now have five months to reinstate terminated coverage after their last paid-through date before a 12-month lockout period will apply.

Recommended Content:

Coronavirus & the MHS Response

MHS Minute: Military Leading the Charge on COVID-19 Research

Video
5/28/2020
MHS Minute: Military Leading the Charge on COVID-19 Research

The military continues to serve on the front lines of research and treatment in response to the COVID-19 pandemic. Tune in to the MHS Minute to learn more.

Recommended Content:

Coronavirus & the MHS Response

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

Publication
5/26/2020

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Recommended Content:

Coronavirus & the MHS Response

COVID-19: Lifestyle Tips to Stay Healthy

Article
5/22/2020
Eating right, physical activity, adequate rest and taking care of our mental health not only improves overall health and wellness, but also makes us more resilient during COVID-19.

As we move toward a third year of the COVID-19 pandemic, the virus has changed many of our daily routines in ways no one anticipated and that have become the new normal.

Recommended Content:

Coronavirus & the MHS Response | Health Readiness & Combat Support | Total Force Fitness

Guidance for Commanders on Risk-Based Changing of Health Protection Condition Levels During the Coronavirus Disease 2019 Pandemic

Publication
5/20/2020

This memorandum provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.

Recommended Content:

Coronavirus & the MHS Response

Resuming Elective Surgical, Invasive, and Dental Procedures in Military Medical and Dental Treatment Facilities

Publication
5/19/2020

This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) may resume elective medical and dental procedures.

Recommended Content:

Public Health | Coronavirus & the MHS Response

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

<< < ... 16 17 18 19 20  ... > >> 
Showing results 286 - 300 Page 20 of 23
Refine your search
Last Updated: August 15, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery